{"id":"has_bled_score","version":"0.0.1-version","templates":[{"id":"has_bled_score","version":"0.1.0"}],"language":"en","updated":"2021-08-24T13:52:48+02:00","authors":[{"name":"Mouna Ghannam","email":"mouna.ghannam@cambio.se"}],"format":"CambioForm.v1","name":"has_bled_score","guidelines":[{"condition":"","execution":[{"id":"HAS_BLED_score","version":"1"}]}],"elements":[{"type":"form","children":[{"type":"container","readonly":false,"hidden":false,"children":[{"type":"row","spanlarge":12,"spanmedium":8,"spansmall":4,"children":[{"type":"column","spanlarge":12,"spanmedium":8,"spansmall":4,"hidden":false,"readonly":false,"children":[{"text":"# HAS\\_BLED Score for Major Bleeding Risk\n\nEstimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.","type":"text","size":"m","position":"left"},{"text":"Divider","type":"divider","size":"s"}]},{"type":"column","spanlarge":6,"spanmedium":4,"spansmall":4,"children":[{"text":"**Input**","type":"text","size":"m","position":"left"},{"type":"input-select","label":"Hypertension","name":"hypertension","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true,"helpertext":"Uncontrolled, >160 mmHg systolic"},{"type":"input-select","label":"Renal disease","name":"abnormal_renal_function","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true,"helpertext":"Dialysis, transplant, Cr >2.26 mg/dL or >200 µmol/L"},{"type":"input-select","label":"Liver disease","name":"abnormal_liver_function","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true,"helpertext":"Cirrhosis or bilirubin >2x normal with AST/ALT/AP >3x normal"},{"type":"input-select","label":"Stroke history","name":"stroke","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true},{"type":"input-select","label":"Prior major bleeding or predisposition to bleeding","name":"bleeding_history_or","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true},{"type":"input-select","label":"Labile INRs","name":"labile_inrs","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true,"helpertext":"Unstable/high INRs, time in therapeutic range <60%"},{"type":"input-select","label":"Age >65","name":"elderly","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true},{"type":"input-select","label":"Medication usage predisposing to bleeding ","name":"drugs_concomitantly","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true,"helpertext":"Aspirin, clopidogrel, NSAIDs"},{"type":"input-select","label":"Alcohol use","name":"alcohol_concomitantly","options":[{"text":"No","value":"at0014","magnitude":0},{"text":"Yes","value":"at0015","magnitude":1}],"clearable":true,"display":"buttons","hidden":false,"readonly":false,"required":true,"helpertext":"≥8 drinks/week"}]},{"type":"column","spanlarge":6,"spanmedium":4,"spansmall":4,"hidden":false,"readonly":false,"children":[{"text":"**Output**","type":"text","size":"m","position":"left","readonly":true},{"type":"input-count","label":"Total score","name":"total_score","min":0,"max":9,"readonly":true},{"type":"input-text","label":"HAS-BLED risk assessment","name":"has-bled_risk_assessment","multiline":false,"readonly":true},{"type":"input-text","label":"Bleeding risk per 100 patient-year","name":"bleeding_risk_per_100","hidden":false,"multiline":false,"readonly":true,"required":false},{"type":"input-text","label":"Recommendation","name":"recommendation","hidden":false,"multiline":false,"readonly":true,"required":false}]}]},{"type":"row","spanlarge":12,"spanmedium":8,"spansmall":4,"children":[{"type":"column","spanlarge":12,"spanmedium":8,"spansmall":4,"hidden":false,"readonly":false,"children":[{"text":"Divider","type":"divider","size":"s"},{"text":"\\-Consider using the HAS-BLED Score instead of, or in conjunction with, other bleeding risk scores such as HEMORR2HAGES and ATRIA to determine risk of major bleeding in a patient with atrial fibrillation.\n\n\\-Consider comparing the risk for major bleeding as calculated by the HAS-BLED Score to the risk for thromboembolic events by the CHADS2 or CHA2DS2-VASc to determine if the benefit of anticoagulation outweighs the risk.","type":"text","size":"m","position":"left"},{"text":"Divider","type":"divider","size":"s"}]}]},{"type":"reset-button","label":"Reset"},{"type":"submit-button","label":"Submit","justify":"end"}]}]}]}